<SEC-DOCUMENT>0001140361-25-019791.txt : 20250519
<SEC-HEADER>0001140361-25-019791.hdr.sgml : 20250519
<ACCEPTANCE-DATETIME>20250519170005
ACCESSION NUMBER:		0001140361-25-019791
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20250519
FILED AS OF DATE:		20250519
DATE AS OF CHANGE:		20250519

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CREDICORP LTD
		CENTRAL INDEX KEY:			0001001290
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14014
		FILM NUMBER:		25964862

	BUSINESS ADDRESS:	
		STREET 1:		CLARENDON HOUSE, 2 CHURCH STREET
		STREET 2:		P.O. BOX HM 666,
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM CX
		BUSINESS PHONE:		5113135140

	MAIL ADDRESS:	
		STREET 1:		CLARENDON HOUSE, 2 CHURCH STREET
		STREET 2:		P.O. BOX HM 666,
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM CX
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ef20049266_6k.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.3.2.5298
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
  <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
  <div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM 6-K</div>
    <div style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Report of Foreign Private Issuer</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to Rule 13a-16 or 15d-16 under the</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Securities Exchange Act of 1934</div>
    <div style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the month of May 2025</div>
    <div style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Commission File Number: 001-14014</div>
    <div style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;">CREDICORP LTD.</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Translation of registrant&#8217;s name into English)</div>
    <div style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Of our subsidiary</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Banco de Credito del Peru:</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Calle Centenario 156</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">La Molina 15026</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Lima, Peru</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font><font style="font-family: 'Times New Roman';">(Address of principal
        executive office)</font></div>
    <div><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
    <div><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Form 20-F &#9746; Form 40-F &#9744;</div>
    <div><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</div>
    <div><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</div>
    <div><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <font style="font-family: 'Times New Roman'; font-size: 10pt;"></font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><img src="image00002.jpg">
      <div><br>
      </div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">May 19, 2025</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Securities and Exchange Commission - SEC</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Re.: MATERIAL EVENT</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Dear Sirs:</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">We hereby notify that, pursuant to the request made by the Peruvian Superintendency of Securities Market through Official Letter N.&#176; 2302-2025-SMV/11.1 and Official
      Letter N.&#176; 2816-2025-SMV/11.1, we complied with the disclosure of the aforementioned Official Letters as a Material Event to the Peruvian Market. The attached Official Letters were translated into English from the original in Spanish.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The information in this Form 6-K (including any exhibits hereto) shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the
      &#8216;Exchange Act&#8217;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Sincerely,</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">/s/ <u>Guillermo Morales</u></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Authorized Representative</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Credicorp Ltd.</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>
    <div><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="text-indent: 29.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
      undersigned, thereunto duly authorized.</div>
    <br>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z62031d324ee940c5834b6fff84ec1aa3">

        <tr>
          <td rowspan="1" style="width: 49.62%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="margin-left: 9pt">
              <div style="margin-left: 9pt">
                <div style="margin-left: 9pt">Date: May 19, 2025</div>
              </div>
            </div>
          </td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 11.69%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 49.62%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 11.69%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.62%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">CREDICORP LTD.</div>
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Registrant)</div>
          </td>
          <td style="width: 11.69%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.62%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          <td style="width: 11.69%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.62%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0);">By:</div>
          </td>
          <td style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0);">/s/ Guillermo Morales</div>
          </td>
          <td style="width: 11.69%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.62%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          <td style="width: 35%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Guillermo Morales</div>
          </td>
          <td style="width: 11.69%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.62%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          <td style="width: 35%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Authorized Representative</div>
          </td>
          <td style="width: 11.69%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        </tr>

    </table>
    <div><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20049266_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.3.2.5298
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);">
  <font style="font-size: 10pt;"> </font>
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 99.1</font><font style="font-size: 10pt;"><br>
    </font></div>
  <div> <font style="font-size: 10pt;"><br>
    </font></div>
  <div style="font-size: 10pt;">
    <div style="text-align: justify;">San Isidro, April 24, 2025</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;"><u>OFFICIAL LETTER No. 2302-2025-SMV/11.1</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;">Mr.</div>
    <div style="text-align: justify; font-weight: bold;">Gianfranco Piero Dario Ferrari de las Casas</div>
    <div style="text-align: justify; font-weight: bold;">Chief Executive Officer</div>
    <div style="text-align: justify; font-weight: bold;">Credicorp Ltd.</div>
    <div style="text-align: justify; font-weight: bold;">Clarendon House 2 Church Street Hm11</div>
    <div style="text-align: justify; font-weight: bold;">Bermuda.-</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;">Ref.: File No. 2025017716</div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 8pt;">I am writing to you in relation to the mandatory legal provisions established in Articles 10 and 30 of the Consolidated Text of the Securities Market Law, Legislative Decree No. 861, approved by
      Supreme Decree No. 020-2023-EF (hereinafter, TUO LMV), as well as the provisions of Article 3 of the Regulation of Material Events and Reserved Information, approved by SMV Resolution No. 005-2014-SMV/01 and its amending regulations (hereinafter,
      Regulation HI), by virtue of which Credicorp Ltd. (hereinafter, Credicorp), as an issuer with securities registered in the Public Registry of the Securities Market &#8211; RPMV, has the obligation to disclose all information about itself and/or its
      economic group that qualifies as a material event, ensuring that its disclosure meets the requirements of truthfulness, sufficiency, and timeliness, and considering that such disclosure is done in the manner and within the timeframe established by
      the Regulation HI.</div>
    <div style="text-align: justify; margin-bottom: 8pt;">It is also necessary to point out that, according to the information provided by your representative in its Economic Group Report<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>, La Esperanza del Per&#250; S.A. (hereinafter, Cl&#237;nica SANNA
      San Borja) and Cl&#237;nica S&#225;nchez Ferrer S.A. (hereinafter, Cl&#237;nica SANNA Trujillo) &#8212;which are part of the SANNA Clinic Network&#8212; belong to the Credicorp Economic Group, with Credicorp being the ultimate controller of the indicated companies.</div>
    <div style="text-align: justify; margin-bottom: 8pt;">In this regard, it should be noted that, since the end of March 2025 and to date, news has been disseminated about the serious events that occurred at Cl&#237;nica SANNA San Borja and Cl&#237;nica SANNA
      Trujillo, related to the administration of defective saline solution to various patients, which has resulted in fatalities. Among that news we have the following:</div>
    <table cellspacing="0" cellpadding="0" id="z3a54319d1ca34a9bb221cd0ec2556b2e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(i)</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>A statement dated March 26, 2025<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup>, in which SANNA reported, among other things, that on Monday, March 24, the pharmaceutical laboratory Medifarma made public that it had marketed a defective batch of saline solution and
              proceeded to withdraw it from its distribution points. They also reported that two patients at Cl&#237;nica SANNA Trujillo, who were administered the saline solution from the mentioned batch, had died. Additionally, they indicated that two
              patients at Cl&#237;nica SANNA San Borja were in critical health condition for the same reason and that they had learned that a person who had initially been treated at that institution with the same saline solution, and later transferred to
              another health center, had also died.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="ze6dd6b483708422989a708f67dd4346b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(ii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>The RPP website on March 26, 2025<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup>, titled "Cl&#237;nica Sanna confirms that two more people died after receiving saline solution observed by the Ministry of Health (Minsa)".</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zda5013eb56bd409b945bc3e7ea62fbfe" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(iii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Semana Economica on March 27, 2025<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">4</sup>, titled "Cl&#237;nica Sanna confirmed two deaths and serious patients due to defective Medifarma saline solution".</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <hr noshade="noshade" align="left" style="height: 2px; width: 30%; color: #000000; background-color: #000000; margin-left: 0px; margin-right: auto; border: none;">
    <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>&#160; Economic Group Report as of April 14, 2025.</div>
    <div style="margin-left: 7.1pt;">Link: <u>https://www.smv.gob.pe/ConsultasP8/documento.aspx?vidDoc=%7b80623696-0000-C85C-9B4F-4575FA66B57E%7d</u></div>
    <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup> Link: https://web.facebook.com/photo/?fbid=1062529522576797&amp;set=comunicado</div>
    <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup> Link: https://rpp.pe/peru/actualidad/clinica-sanna-confirma-que-dos-personas-mas-murieron-trasrecibir-suero-fisiologico-observado-por-el-minsa-noticia-1624470</div>
    <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">4</sup> Link: https://www.semanaeconomica.com/sectores-empresas/salud/clinica-sanna-confirmo-dos-fallecidos-y-pacientes-graves-por-suero-defectuoso-de-medifarma</div>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z7fffba45f0f248488f3f66de091b8122" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(iv)</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Press Release No. 007-2025 dated March 29, 2025<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">5</sup>, in which the Ministry of Health &#8211; MINSA, through its Attorney General's Office, reported having "criminally denounced Cl&#237;nica SANNA and those responsible for failing to report in
              a timely manner (within the required 24 hours) the first serious adverse reaction that resulted in death, notifying it only a month later".</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z392d6f5de0d54c7fb2756ec1583cb219" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(v)</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>The Infobae website on April 1, 2025<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup>, titled "Ministry of Health (Minsa): Sanna alerted about the death of a patient due to defective Medifarma saline solution one month after the death".</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z7e30b3fcb6ed465a996d5a79b76e35df" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(vi)</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Diario Gestion on April 1, 2025<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">7</sup>, titled "Defective saline solution: SANNA gives its version of why its Trujillo clinic could not identify it".</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z764f6836b773467eb4c5a846a879e786" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(vii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>The Ojo Publico website on April 13, 2025<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">8</sup>, titled "Medifarma case: the defective saline solution that exposed cracks in the health system".</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zf9ba88a038a24beba528e0bcf922ad69" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(viii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>The RPP website on April 17, 2025<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">9</sup>, titled "Nurse who was in critical condition after being administered saline solution at Cl&#237;nica Sanna dies".</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z1ea80e80658f4789b9327238788e9efb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(ix)</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>El Comercio website on April 19, 2025<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">10</sup>, titled "Architect dies after being in brain death for a month: the number of victims of Medifarma's defective saline solution rises to 7".</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-bottom: 8pt;">Consequently, without prejudice to the determination of responsibilities that may arise, within the framework of the oversight actions of the General Office of Conduct Supervision &#8211; IGSC, based on
      the provisions of Article 27, numeral 27.3, of the Regulation HI, and considering the aforementioned events, your representative is required to do the following:</div>
    <table cellspacing="0" cellpadding="0" id="z45a2bfb9a2c24de4800a650179ccacf3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Explain the reasons why your representative has not yet disclosed as a relevant event all the information related to the events that occurred at Cl&#237;nica SANNA San Borja and Cl&#237;nica SANNA Trujillo.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z047fd6669e4a4f2b89729fa6b3f8dfb5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Disclose all the information related to the administration of defective saline solution to various patients in the SANNA Clinic Network.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z7b562406b80e4784bd1769d0707aab98" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Confirm and/or clarify all the information about the judicial process initiated by the Ministry of Health (MINSA) against the SANNA Clinic Network.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zfe7ca89dca59428c8a0834e052e79935" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Inform whether there are any administrative processes initiated by Peruvian State authorities against any of the clinics in the SANNA Clinic Network, belonging to your economic group, or against their respective officials.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z1a36113d9da0469f9fc53f4cd89772c0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Provide detailed information on all the agreements adopted by the governing bodies of your representative or the companies in your economic group in relation to the serious events indicated. If no agreement has been adopted, inform this
              situation, indicating the reasons.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zf6d0ffd4af724f439bd0fd3441a64579" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Provide all information related to the economic/financial impact generated by the aforementioned events and their consequences on your representative and/or the companies in your economic group, as well as the measurement of such impact to
              date.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z947ac39bee014d73a8f8f5b7e3ebcfc0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Provide all information related to the measurement of the reputational impact on your representative and the companies in your economic group.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z03bbd5c304924e23aca3e53dfe434afd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 8pt;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 10pt;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div>Provide detailed information on any other relevant additional information on the matters of this official letter.</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="font-size: 10pt;">
    <hr noshade="noshade" align="left" style="height: 2px; width: 30%; color: #000000; background-color: #000000; margin-left: 0px; margin-right: auto; border: none;">
    <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> 5</sup> Link: https://www.gob.pe/institucion/minsa/noticias/1136391-comunicado-de-prensa-n-007-2025</div>
    <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup> Link: https://www.infobae.com/peru/2025/04/01/sanna-alerto-sobre-muerte-de-paciente-por-suero-defectuoso-de-medifarma-un-mes-despues-del-deceso-segun-minsa/</div>
    <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">7</sup> Link: https://gestion.pe/peru/suero-defectuoso-sanna-da-su-version-de-el-porque-su-clinica-de-trujillo-no-pudo-identificarlo-noticia/</div>
    <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">8</sup> Link: https://ojo-publico.com/derechos-humanos/salud/medifarma-el-caso-que-expuso-las-grietas-del-sistema-sanitario</div>
    <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">9</sup> Link: https://rpp.pe/lima/actualidad/fallece-enfermera-que-se-encontraba-en-estado-critico-tras-aplicarle-suero-fisiologico-en-clinica-sanna-noticia-1629204</div>
    <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">10</sup> Link: https://elcomercio.pe/lima/sucesos/medifarma-fallece-arquitecta-de-26-anos-tras-permanecer-un-mes-con-muerte-cerebral-ya-son-7-las-victimas-del-suero-defectuoso-sanna-san-borja-ultimas-noticia/</div>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 8pt;">This requirement must be met within a maximum period of two (02) business days from the notification of this official letter, through the corresponding route of the "Material Events " of the MVNet
      System; notwithstanding this, you must proceed to publish this official letter immediately through the Material Events route.</div>
    <div style="text-align: justify; margin-bottom: 8pt;">Finally, your representative is required, in compliance with the cited regulations, to fulfill its obligation to keep the market informed of any act, agreement, fact, ongoing negotiation, decision,
      or set of circumstances with significant influence, taking the necessary measures to ensure full compliance with the obligations arising from the securities market regulations, as well as to address the requirements made by the Superintendence of
      Securities Market.</div>
    <div style="text-align: justify;">Without further ado, I remain at your disposal.</div>
    <div><br>
    </div>
    <div>Sincerely,</div>
    <div><br>
    </div>
    <div>Alix Godos</div>
    <div>Head of Conduct Supervision</div>
    <div>General Office of Conduct Supervision</div>
    <div><br>
    </div>
    <div>JHT/EVC</div>
    <div>C.C. Lima Stock Exchange S.A.</div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ef20049266_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.3.2.5298
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);">
  <font style="font-size: 10pt;"> </font>
  <hr noshade="noshade" align="center" style="height: 4px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto; border: medium none; font-size: 10pt;"><br>
  <div style="font-size: 10pt;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.2</font><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: justify;">San Isidro, May 15, 2025</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-weight: bold;"><u>OFFICIAL LETTER No. 2816-2025-SMV/11.1</u></div>
      <div><br>
      </div>
      <div style="text-align: justify; font-weight: bold;">Mr.</div>
      <div style="text-align: justify; font-weight: bold;">Gianfranco Piero Dario Ferrari de las Casas</div>
      <div style="text-align: justify; font-weight: bold;">Chief Executive Officer</div>
      <div style="text-align: justify; font-weight: bold;">Credicorp Ltd.</div>
      <div style="text-align: justify; font-weight: bold;">Clarendon House 2 Church Street Hm11</div>
      <div style="text-align: justify;"><font style="font-weight: bold;"><u>Bermuda</u></font>.-</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf015d9437b62484eaec805af6e642144" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 36pt; font-size: 10pt;">
                <div style="text-align: justify;">Ref.:</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; font-size: 10pt;">File No. 2025017716</div>
                <div style="text-align: justify; font-size: 10pt;">Official Letter No. 2302-2025-SMV/11.1</div>
                <div style="text-align: justify;"><font style="font-size: 10pt;">Letter dated April 24, 2025</font> </div>
                <div style="text-align: justify;"><font style="font-size: 10pt;"> </font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify;"><br>
      </div>
      <div style="text-align: justify;">Dear Sir,</div>
      <div><br>
      </div>
      <div style="text-align: justify;">I am writing to you regarding the following:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z5337edb78c9b41efbb0d9b2db9beae50">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div>Official Letter No. 2302-2025-SMV/11.1 (hereinafter, &#8220;Official Letter No. 2302&#8221;), through which the General Office of Conduct Supervision (IGSC) made several requests for information to Credicorp Ltd. (hereinafter, &#8220;Credicorp&#8221;) regarding
                the serious incidents that occurred within the SANNA Clinic Network, related to the administration of defective saline solution to various patients, which&#160;resulted in fatalities. Additionally, Credicorp was requested to immediately disclose
                the Official Letter No. 2302 as a material event, notwithstanding the deadline granted for responding to the information requests.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="ze4cad83d758b458f8d11bd0c489f7549">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div>Letter dated April 24, 2025, in which Credicorp responded to Official Letter No. 2302.</div>
            </td>
          </tr>

      </table>
      <div style="margin-bottom: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" align="center" style="border-collapse: collapse; width: 80%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 9pt; text-align: left;" id="zfc665573c2f6407594794c203550ab56">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-size: 10pt;">April 24, 2025</div>
              <div style="font-size: 10pt;"> <br>
              </div>
              <div style="font-size: 10pt;">SUPERINTENDENCY OF THE SECURITIES MARKET &#8211; SMV</div>
              <div style="font-size: 10pt;"> <br>
              </div>
              <div style="margin-top: 0px; margin-bottom: 0px; font-size: 10pt;">Attn.: Mr. Alix Godos &#8211; Head of Conduct Supervision</div>
              <div style="margin-top: 0px; margin-bottom: 0px; font-size: 10pt; margin-left: 18pt;">General Office of Conduct Supervision</div>
              <div style="margin-top: 0px; margin-bottom: 0px; font-size: 10pt; margin-left: 18pt;"> <br>
              </div>
              <div style="font-size: 10pt;">Ref.: Official Letter No. 2302-2025-SMV/11.1</div>
              <div style="font-size: 10pt;"> <br>
              </div>
              <div style="font-size: 10pt;">Dear Sirs,</div>
              <div style="font-size: 10pt;"> <br>
              </div>
              <div style="font-size: 10pt; text-align: justify;">In response to the referenced Official Letter, we consider that the entity best positioned to respond and inform the market regarding the matters indicated therein is Pac&#237;fico Compa&#241;&#237;a de
                Seguros y Reaseguros S.A. (hereinafter, &#8220;Pac&#237;fico&#8221;), in its capacity as direct shareholder of Pac&#237;fico S.A. Entidad Prestadora de Salud, owner of La Esperanza del Per&#250; S.A. (Cl&#237;nica SANNA San Borja) and Cl&#237;nica S&#225;nchez Ferrer S.A. (Cl&#237;nica
                SANNA Trujillo). Accordingly, we respectfully request that this Superintendency redirect the aforementioned request to Pac&#237;fico so that it may address the matter. It is worth noting that Pac&#237;fico is a company whose shares are registered in
                the Public Registry of the Securities Market.</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="font-size: 10pt; text-align: justify;">Sincerely,</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="font-size: 10pt; font-weight: bold; text-align: justify;">CREDICORP LTD.</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="za0ed12c9d20c46fea5f46f09a307cda4">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div>Letter dated April 28, 2025, through which Credicorp stated: &#8220;(&#8230;) we would like to reiterate our communication dated April 24, 2025, a copy of which is attached, and we remain attentive to your response at your earliest convenience.&#8221;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify;">In this regard, it is necessary to reiterate that, according to the Economic Group Report<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> submitted by your company, <font style="font-weight: bold;"><u>Credicorp exercises final control over the
            economic group known as &#8220;Credicorp&#8221;,</u></font> which includes La Esperanza del Per&#250; S.A. and Cl&#237;nica S&#225;nchez Ferrer S.A. Therefore, the Official Letter was addressed to Credicorp in <font style="font-weight: bold;"><u>its capacity as the
            ultimate controller of the SANNA Clinic Network</u></font>, which is part of its economic group<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup>.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Furthermore, pursuant to Articles 10 and 30 of the Consolidated Text of the Securities Market Law, Legislative Decree No. 861, approved by Supreme Decree No. 020-2023-EF (hereinafter, TUO LMV), as well as the
        provisions of Article 3 of the Regulation on Material Events and Reserved Information, approved by SMV Resolution No. 005-2014-SMV/01 and its amendments (hereinafter, Regulation HI), <font style="font-weight: bold;"><u>Credicorp</u></font>, as an
        issuer with securities registered in the Public Registry of the Securities Market (RPMV) and as the controller of the &#8220;Credicorp&#8221; economic group, <font style="font-weight: bold;"><u>has the obligation to disclose all information about itself
            and/or its economic group that qualifies as a material event</u></font>, ensuring that its disclosure meets the requirements of truthfulness, sufficiency, and timeliness, and considering that such disclosure is done in the manner and within the
        timeframe established by the Regulation HI.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Therefore, without prejudice to the determination of responsibilities that may arise, and within the framework of the SMV&#8217;s supervisory actions, and pursuant to Article 27 of the Regulation HI, Credicorp is hereby
        required to, within a maximum of two (2) business days from notification of this official letter, comply with the requests made in Official Letter No. 2302 through the corresponding route of the "Material Events " of the MVNet System.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Additionally, Credicorp is required to immediately disclose both Official Letter No. 2302 and this official letter through the corresponding route of the "Material Events " of the MVNet System. Failure to do so will
        result in the SMV proceeding with the disclosure itself, pursuant to Article 27.1 of the Regulation HI.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Finally, we reiterate that your company must comply with its obligation to keep the market informed of any act, agreement, fact, ongoing negotiation, decision, or set of circumstances with significant influence on
        the market, taking the necessary measures to ensure full compliance with the obligations arising from the securities market regulations, as well as to address the requirements made by the SMV. It is important to note that failure to comply with
        these requirements constitutes a sanctionable offense under Section 1.1, Item 1, Part B, Annex II of the Sanctions Regulation, approved by SMV Resolution No. 035-2018-SMV/01.</div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="left" style="height: 2px; width: 30%; color: #000000; background-color: #000000; margin-left: 0px; margin-right: auto; border: none;">
        <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> Economic Group Report as of April 14, 2025. Link:</div>
        <div><u>https://www.smv.gob.pe/ConsultasP8/documento.aspx?vidDoc=%7b80623696-0000-C85C-9B4F-4575FA66B57E%7d</u></div>
        <div style="text-align: justify;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup> The SANNA Clinic Network is composed &#8212; among others &#8212; of Sistemas de Administraci&#243;n Hospitalaria S.A.C., La Esperanza del Per&#250; S.A. (Cl&#237;nica San Borja), and Cl&#237;nica S&#225;nchez Ferrer S.A. (located in
          Trujillo), all of which are controlled by Pac&#237;fico S.A. Entidad Prestadora de Salud. In turn, Pac&#237;fico S.A. is jointly owned by Pac&#237;fico Compa&#241;&#237;a de Seguros y Reaseguros S.A. (50%) and Grupo Cr&#233;dito S.A. (50%), both of which are subsidiaries of
          Credicorp Ltd.</div>
        <div style="text-align: justify;"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify;">Sincerely,</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Alix Godos</div>
      <div style="text-align: justify;">Head of Conduct Supervision</div>
      <div style="text-align: justify;">General Office of Conduct Supervision</div>
      <div><br>
      </div>
      <div style="text-align: justify;">JH/EV</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zf6f1d6594b664fb58825e0cbfea17883">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-size: 10pt;">Cc:</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div>Pac&#237;fico Compa&#241;&#237;a de Seguros y Reaseguros S.A.</div>
              <div>Lima Stock Exchange S.A. </div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt;"><br>
      </div>
    </div>
  </div>
  <font style="font-size: 10pt;"><br>
  </font>
  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  W 0L# 2(  A$! Q$!_\0
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MCKG@9QCC-6?VS+.:?X:Z?<Q*S16NI(\N.@!1U!/XD#\:]E\'ZI:ZWX5TG4K
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!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
